BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24957843)

  • 1. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.
    Gross AE; Van Schooneveld TC; Olsen KM; Rupp ME; Bui TH; Forsung E; Kalil AC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5262-8. PubMed ID: 24957843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

  • 3. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
    Wu CL; Ku SC; Yang KY; Fang WF; Tu CY; Chen CW; Hsu KH; Fan WC; Lin MC; Chen W; Ou CY; Yu CJ
    J Formos Med Assoc; 2013 Jan; 112(1):31-40. PubMed ID: 23332427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia].
    Taşbakan MS; Bacakoğlu F; Başoğlu OK; Gürgün A; Başarik B; Citim Tuncel S; Sayiner A
    Tuberk Toraks; 2011; 59(4):348-54. PubMed ID: 22233304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspective of the HCAP problem: is it CAP or is it HAP?
    Polverino E; Torres A
    Semin Respir Crit Care Med; 2009 Apr; 30(2):239-48. PubMed ID: 19296421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.
    Hyun H; Song JY; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ
    PLoS One; 2022; 17(6):e0270261. PubMed ID: 35767562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study.
    Bjarnason A; Asgeirsson H; Baldursson O; Kristinsson KG; Gottfredsson M
    Infect Dis (Lond); 2015 Mar; 47(3):130-6. PubMed ID: 25664503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization.
    Garcia-Vidal C; Viasus D; Roset A; Adamuz J; Verdaguer R; Dorca J; Gudiol F; Carratalà J
    Clin Microbiol Infect; 2011 Nov; 17(11):1659-65. PubMed ID: 21463391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia.
    Giannella M; Pinilla B; Capdevila JA; Martínez Alarcón J; Muñoz P; López Álvarez J; Bouza E;
    Clin Microbiol Infect; 2012 Aug; 18(8):786-94. PubMed ID: 22284436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-based antibiotics and mortality in healthcare-associated pneumonia.
    Madaras-Kelly KJ; Remington RE; Sloan KL; Fan VS
    J Gen Intern Med; 2012 Jul; 27(7):845-52. PubMed ID: 22396110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study.
    Vallés J; Martin-Loeches I; Torres A; Diaz E; Seijas I; López MJ; Garro P; Castillo C; Garnacho-Montero J; Martin Mdel M; de la Torre MV; Olaechea P; Cilloniz C; Almirall J; García F; Jiménez R; Seoane E; Soriano C; Mesalles E; Posada P
    Intensive Care Med; 2014 Apr; 40(4):572-81. PubMed ID: 24638939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk Factors of Multidrug-Resistant Organisms in Hospitalized Patients with Community-Acquired Pneumonia in Dr. Soetomo Hospital Surabaya, Indonesia.
    Soedarsono S; Widyaningsih PD; Mertaniasih NM
    Acta Med Indones; 2021 Apr; 53(2):169-176. PubMed ID: 34251345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea.
    Jeon EJ; Cho SG; Shin JW; Kim JY; Park IW; Choi BW; Choi JC
    Yonsei Med J; 2011 Mar; 52(2):282-7. PubMed ID: 21319347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome.
    Micek ST; Reichley RM; Kollef MH
    Medicine (Baltimore); 2011 Nov; 90(6):390-395. PubMed ID: 22033455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.